Full-Time

Contract – Senior Study Start-Up Specialist

Posted on 9/11/2024

Cytokinetics

Cytokinetics

501-1,000 employees

Develops drugs for muscle function disorders

Biotechnology
Healthcare

Senior

Remote in USA

Category
Healthcare Administration & Support
Medical, Clinical & Veterinary
Required Skills
Data Analysis
Requirements
  • University Degree or equivalent, preferably in a medical/science-related field with 8+ years of related experience
  • Demonstrated knowledge and understanding of clinical trials and experience in managing projects.
  • Demonstrated knowledge and understanding of International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use (ICH)
Responsibilities
  • Update knowledge on related regulatory requirements, ensures adherence and compliance with local regulations and internal procedures
  • Execute all start-up activities prior to site activation on assigned studies, according to CYTK standards and aligned with study/project requirements and timelines
  • Prepare Informed Consent Form (ICF) and obtains ethics committees’ and local regulatory authorities’ approval. Prepares ongoing submissions, amendments and periodic notifications required by ethics committees and regulatory authorities as needed within the country
  • Analyze and maintain study start-up data (metrics) on assigned studies, ensuring optimal efficiency to reduce start-up timelines and identify opportunities for continuous improvement
  • Partner with Clinical Trial Managers to provide guidance on regulatory/ethics requirements, to track and drive site activations and trial amendments submissions, by regularly reviewing and monitoring status of submissions/activations
  • Support drug label preparation and approval (as local label representative) for studies in collaboration with local Regulatory/Quality department, as required.
  • Liaise and collaborates with relevant authorities/bodies to further enhance clinical trial process, government policies! laws, via innovative approaches
  • Collaborate with CTMs to identify and track new investigator sites performing feasibility, as applicable, and develops and supports effective patient recruitment and retention practices, as required
  • Responsible for study budget and contracts negotiation in collaboration with Contracts Manager/Associate, as required and ensures compliance with Fair Market Value (FMV) in the country

Cytokinetics focuses on developing medicines that improve muscle function for patients with cardiovascular and neuromuscular diseases. Their products are small molecule drugs designed to either enhance or inhibit muscle function, tailored to specific therapeutic needs. The company has a range of drugs in clinical trials, including omecamtiv mecarbil and reldesemtiv, aimed at treating conditions like heart failure, hypertrophic cardiomyopathy, amyotrophic lateral sclerosis, and spinal muscular atrophy. Unlike many competitors, Cytokinetics emphasizes rigorous scientific research and has conducted over 50 clinical trials to ensure the effectiveness of its treatments. The goal is to bring new therapies to market that address the unmet needs of patients suffering from debilitating muscle-related conditions.

Company Stage

IPO

Total Funding

$58.4M

Headquarters

South San Francisco, California

Founded

1998

Growth & Insights
Headcount

6 month growth

2%

1 year growth

1%

2 year growth

14%
Simplify Jobs

Simplify's Take

What believers are saying

  • Cytokinetics secured $575M funding from Royalty Pharma for aficamten's commercial launch.
  • Positive Phase III trial results for aficamten show significant improvements in HCM treatment.
  • Public offering priced at $51/share expected to raise $500M, indicating strong market confidence.

What critics are saying

  • Competition from Bristol-Myers Squibb's Camzyos could impact aficamten's market share.
  • Reliance on successful clinical trials poses financial risks if outcomes are negative.
  • Financial strategy depends on external funding, risking instability if partnerships fail.

What makes Cytokinetics unique

  • Cytokinetics focuses on muscle activators and inhibitors for cardiovascular and neuromuscular diseases.
  • The company has a robust pipeline including omecamtiv mecarbil and aficamten.
  • Cytokinetics educates healthcare professionals on hypertrophic cardiomyopathy through 'HCM Beyond the Heart' campaign.

Help us improve and share your feedback! Did you find this helpful?

INACTIVE